INBX - Inhibrx Biosciences Inc.
73.5
1.870 2.544%
Share volume: 122,565
Last Updated: 03-11-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$71.63
1.87
0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-14-2024 | 03-17-2025 | 05-14-2025 | 11-13-2025 | |
| Cash flow financing | 38.728 M | 0.000 | 0.000 | 0.000 | 99.840 M | 352.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 352.000 K | |
| Cash flow | -63.050 M | 0.000 | 0.000 | 0.000 | 63.924 M | -33.479 M | |
| Net income | -78.710 M | 1.858 B | -43.864 M | 0.000 | -43.311 M | -35.256 M | |
| Depreciation | 360.000 K | 0.000 | 760.000 K | 689.000 K | 675.000 K | 583.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 3.038 M | 0.000 | 0.000 | 0.000 | -183.000 K | 0.000 | |
| Investing Cashflow | -1.119 M | 0.000 | -247.000 K | -16.000 K | -21.000 K | -7.000 K | |
| Net Borrowings | -60.612 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -1.119 M | 0.000 | 247.000 K | 0.000 | 21.000 K | 10.000 K | |
| Cash Change | 252.483 M | 0.000 | -30.528 M | -43.736 M | 63.924 M | -33.479 M |